EarningsQ3 2023 Earnings Report

Arrowhead Pharmaceuticals (ARWR) Q3 2023 Earnings Report

0 Followers

MX:ARWR Q3 2023 EPS Results

Actual EPS-$17.68

Consensus EPS-$10.48

Beat/MissMissed by -$7.20

One Year Ago EPS-$12.52

Actual Revenue$291.40M

Expected Revenue$836.43M

Beat/MissMissed by -$545.02M

YoY Revenue Growth-51.18%

QuarterQ3 2023

Date08/07/2023

TimeAfter Close

Conference CallMonday, August 7, 2023

MX:ARWR Upcoming Earnings

Arrowhead Pharmaceuticals's next earnings date is estimated for November 30, 2026, based on past reporting schedules.

MX:ARWR Q3 2023 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 30, 2026	2026 (Q4)	-28.56 / -	-2.026	―
Aug 04, 2026	2026 (Q3)	-23.51 / -25.04	-23.202	-7.94% (-1.84)
May 07, 2026	2026 (Q2)	-20.16 / -17.13	50.639	-133.82% (-67.76)
Feb 05, 2026	2026 (Q1)	0.68 / 4.05	-25.596	115.83% (+29.65)
Nov 25, 2025	2025 (Q4)	-2.06 / -2.03	-25.043	91.91% (+23.02)
Aug 07, 2025	2025 (Q3)	-17.53 / -23.20	-25.412	8.70% (+2.21)
May 12, 2025	2025 (Q2)	-3.44 / 50.64	-18.782	369.61% (+69.42)
Feb 10, 2025	2025 (Q1)	-8.77 / -25.60	-22.834	-12.10% (-2.76)
Nov 26, 2024	2024 (Q4)	-20.62 / -25.04	-18.782	-33.33% (-6.26)
Aug 08, 2024	2024 (Q3)	-9.74 / -25.41	-17.678	-43.75% (-7.73)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed